Patents by Inventor Marina Maria BOIDO

Marina Maria BOIDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HALOPERIDOL FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY
    Publication number: 20240390356
    Abstract: Haloperidol, or a pharmaceutically acceptable salt, ester or solvate thereof, as well as pharmaceutical compositions comprising the same, for use in methods for preventing and/or treating spinal muscular atrophy, are described.
    Type: Application
    Filed: December 20, 2022
    Publication date: November 28, 2024
    Inventors: Piotr Tadeusz KONIECZNY, Rubén Darío ARTERO ALLEPUZ, Camille JANUEL, Cécile MARTINAT, Marina Maria BOIDO, Giovanna MENDUTI
  • Muscle performance improvement compounds comprising C-terminus agrin fragment and an ACTR2B inhibitor
    Patent number: 11407799
    Abstract: A compound comprising at least two components, a first component being the nLG3 or (h)nLG3 domain from the C-terminus of mouse or human agrin, and at least one second component, selected from proteins or an antagonistic antibody that inhibit ActR2B-induced signaling activity in the presence of myostatin, the components being linked by means of linking entities. Such compounds are effective treatments for neuromuscular diseases and problems.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: August 9, 2022
    Assignee: PHARMAFOX THERAPEUTICS AG
    Inventors: Jan Willem Vrijbloed, Marina Maria Boido, Olena Butenko, Roberta Schellino
  • MUSCLE PERFORMANCE IMPROVEMENT COMPOUNDS
    Publication number: 20210253654
    Abstract: A compound comprising at least two components, a first component being the nLG3 or (h)nLG3 domain from the C-terminus of mouse or human agrin, and at least one second component, selected from proteins or an antagonistic antibody that inhibit ActR2B-induced signaling activity in the presence of myostatin, the components being linked by means of linking entities. Such compounds are effective treatments for neuromuscular diseases and problems.
    Type: Application
    Filed: November 28, 2017
    Publication date: August 19, 2021
    Inventors: Jan Willem VRIJBLOED, Marina Maria BOIDO, Olena BUTENKO, Roberta SCHELLINO